Literature DB >> 27022246

Protective effects of honokiol on ischemia/reperfusion injury of rat ovary: an experimental study.

Senem Yaman Tunc1, Elif Agacayak1, Neval Yaman Goruk2, Mehmet Sait Icen1, Abdulkadir Turgut1, Ulas Alabalik3, Cihan Togrul4, Cenap Ekinci5, Aysun Ekinci6, Talip Gul1.   

Abstract

AIM: The purpose of this study was to investigate the protective effect of honokiol on experimental ischemia/reperfusion injury of rat ovary.
MATERIALS AND METHODS: A total of 40 female Wistar albino rats were used in this study. The rats were divided into five groups as follows: sham (Group I), torsion (Group II), torsion + detorsion (Group III), torsion + detorsion + saline (Group IV), and torsion + detorsion + honokiol (Group V). Bilateral adnexa in all the rats except for those in the sham group were exposed to torsion for 3 hours. The rats in Group IV were administered saline, whereas the rats in Group V were administered honokiol by intraperitoneal route 30 minutes before detorsion. Tissue and plasma concentrations of malondialdehyde and nitric oxide were determined. Ovarian tissue was histologically evaluated. Data analyses were performed by means of Kruskal-Wallis test and Mann-Whitney U-test (Bonferroni correction) in SPSS 15.0 (Statistical Package for Social Sciences; SPSS Inc., Chicago, IL, USA).
RESULTS: The torsion and detorsion groups had higher scores in vascular congestion, hemorrhage, and inflammatory cell infiltration compared with the sham group (P<0.005). In addition, total histopathological scores were significantly higher in the torsion and detorsion groups compared with the sham group (P<0.005). A significant reduction was observed in hemorrhage, inflammatory cell infiltration, and cellular degeneration scores, of all histopathological scores, in the honokiol group (P<0.005). Ovarian tissue concentrations of malondialdehyde were significantly higher in the torsion and detorsion groups compared with the sham and honokiol groups (P<0.005). Ovarian tissue concentrations of nitric oxide, on the other hand, were significantly higher in the torsion group compared with the sham, saline, and honokiol groups (P<0.005).
CONCLUSION: Honokiol has a beneficial effect on ovarian torsion-related ischemia/reperfusion injury.

Entities:  

Keywords:  honokiol; ischemia/reperfusion injury; malondialdehyde; nitric oxide; ovary

Mesh:

Substances:

Year:  2016        PMID: 27022246      PMCID: PMC4789835          DOI: 10.2147/DDDT.S93768

Source DB:  PubMed          Journal:  Drug Des Devel Ther        ISSN: 1177-8881            Impact factor:   4.162


  34 in total

Review 1.  The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation.

Authors:  Walter G Land
Journal:  Transplantation       Date:  2005-03-15       Impact factor: 4.939

Review 2.  Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows.

Authors:  S Kuroda; B K Siesjö
Journal:  Clin Neurosci       Date:  1997

3.  Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.

Authors:  Anfernee Kai-Wing Tse; Chi-Keung Wan; Xiao-Ling Shen; Mengsu Yang; Wang-Fun Fong
Journal:  Biochem Pharmacol       Date:  2005-09-21       Impact factor: 5.858

Review 4.  Adnexal torsion.

Authors:  Gabriel Oelsner; David Shashar
Journal:  Clin Obstet Gynecol       Date:  2006-09       Impact factor: 2.190

Review 5.  Free radicals in disease processes: a compilation of cause and consequence.

Authors:  J M Gutteridge
Journal:  Free Radic Res Commun       Date:  1993

6.  Reperfusion injury after detorsion of unilateral testicular torsion.

Authors:  F M Akgür; K Kilinç; T Aktuğ
Journal:  Urol Res       Date:  1993

7.  Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method.

Authors:  N K Cortas; N W Wakid
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

Review 8.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.

Authors:  Daniele Del Rio; Amanda J Stewart; Nicoletta Pellegrini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-08       Impact factor: 4.222

9.  Damage to the endoplasmic reticulum and activation of apoptotic machinery by oxidative stress in ischemic neurons.

Authors:  Takeshi Hayashi; Atsushi Saito; Shuzo Okuno; Michel Ferrand-Drake; Robert L Dodd; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2005-01       Impact factor: 6.200

10.  Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth.

Authors:  Meei Ling Sheu; Shing Hwa Liu; Keng Hsin Lan
Journal:  PLoS One       Date:  2007-10-31       Impact factor: 3.240

View more
  4 in total

1.  The Protective Effects of Alpha-Lipoic Acid and Coenzyme Q10 Combination on Ovarian Ischemia-Reperfusion Injury: An Experimental Study.

Authors:  Ahmet Ali Tuncer; Mehmet Fatih Bozkurt; Tulay Koken; Nurhan Dogan; Mine Kanat Pektaş; Didem Baskin Embleton
Journal:  Adv Med       Date:  2016-08-15

2.  Magnesium: does it reduce ischemia/reperfusion injury in an adnexal torsion rat model?

Authors:  Ebru Celik Kavak; Funda Gulcu Bulmus; Ozgur Bulmus; Salih Burcin Kavak; Nevin Kocaman
Journal:  Drug Des Devel Ther       Date:  2018-02-28       Impact factor: 4.162

3.  Honokiol Ameliorates Myocardial Ischemia/Reperfusion Injury in Type 1 Diabetic Rats by Reducing Oxidative Stress and Apoptosis through Activating the SIRT1-Nrf2 Signaling Pathway.

Authors:  Bin Zhang; Mengen Zhai; Buying Li; Zhenhua Liu; Kaifeng Li; Liqing Jiang; Meng Zhang; Wei Yi; Jian Yang; Dinghua Yi; Hongliang Liang; Zhenxiao Jin; Weixun Duan; Shiqiang Yu
Journal:  Oxid Med Cell Longev       Date:  2018-02-20       Impact factor: 6.543

4.  Honokiol Provides Cardioprotection from Myocardial Ischemia/Reperfusion Injury (MI/RI) by Inhibiting Mitochondrial Apoptosis via the PI3K/AKT Signaling Pathway.

Authors:  Linhua Lv; Qiuhuan Kong; Zhiying Li; Ying Zhang; Bijiao Chen; Lihua Lv; Yubi Zhang
Journal:  Cardiovasc Ther       Date:  2022-03-27       Impact factor: 3.023

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.